How do recall rate, PPV, and CDR relate to program quality?

How do recall rate, PPV, and CDR relate to program quality?

• A. Lower recall with higher PPV and higher CDR is preferred, balancing sensitivity and specificity
• B. Higher recall and higher PPV are always better
• C. CDR does not affect program quality
• D. PPV measures recalls per screen

Answer: (A)

In screening programs, quality comes from catching as many cancers as possible while keeping the burden of recalls low and the chance that a recall is truly cancer high. Recall rate tells you how often people are asked to come back for more tests. A high recall rate can flag more cancers but also increases unnecessary anxiety and procedures, so it tends to lower the overall efficiency unless the additional cancers found justify it. Positive predictive value shows how likely a recalled case actually has cancer; a higher PPV means most recalls are true positives, reducing unnecessary work and distress. Cancer detection rate measures how many cancers are found per number of screens; a higher rate means cancers are being found more often, which is good for early treatment and outcomes. The best balance for program quality is to keep the recall rate low while maintaining a high PPV and a high cancer detection rate. That way, most recalls are meaningful (high PPV), cancers are being identified (high CDR), and you’re not burdening many people with unnecessary recalls (low recall rate). This reflects a good balance between sensitivity (finding cancers) and specificity (avoiding false positives). If you push recall higher, you may detect more cancers but at the cost of more false positives and a lower PPV. Conversely, focusing only on PPV or only on CDR can miss the broader goal of efficient, effective screening.

In screening programs, quality comes from catching as many cancers as possible while keeping the burden of recalls low and the chance that a recall is truly cancer high. Recall rate tells you how often people are asked to come back for more tests. A high recall rate can flag more cancers but also increases unnecessary anxiety and procedures, so it tends to lower the overall efficiency unless the additional cancers found justify it. Positive predictive value shows how likely a recalled case actually has cancer; a higher PPV means most recalls are true positives, reducing unnecessary work and distress. Cancer detection rate measures how many cancers are found per number of screens; a higher rate means cancers are being found more often, which is good for early treatment and outcomes.

The best balance for program quality is to keep the recall rate low while maintaining a high PPV and a high cancer detection rate. That way, most recalls are meaningful (high PPV), cancers are being identified (high CDR), and you’re not burdening many people with unnecessary recalls (low recall rate). This reflects a good balance between sensitivity (finding cancers) and specificity (avoiding false positives).

If you push recall higher, you may detect more cancers but at the cost of more false positives and a lower PPV. Conversely, focusing only on PPV or only on CDR can miss the broader goal of efficient, effective screening.